Therapeutic removal of internally deposited transuranium elements.
D000336:Aerosols; D000576:Americium / Q000009:adverse effects; D000818:Animals; D001603:Berkelium / Q000009:adverse effects; D002142:Californium / Q000009:adverse effects; D002614:Chelating Agents / Q000627:therapeutic use; D003476:Curium / Q000009:adverse effects; D004540:Einsteinium / Q000009:adverse effects; D006207:Half-Life; D009405:Neptunium / Q000009:adverse effects; D004369:Pentetic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D011005:Plutonium / Q000009:adverse effects; D011832:Radiation Injuries / Q000188:drug therapy* / Q000209:etiology; D011854:Radiochemistry; D011868:Radioisotopes / Q000009:adverse effects*; D051381:Rats
D000336:Aerosols; D002614:Chelating Agents; D011868:Radioisotopes; D001603:Berkelium; D011005:Plutonium; D009405:Neptunium; D004369:Pentetic Acid; D002142:Californium; D003476:Curium; D000576:Americium; D004540:Einsteinium